Stocks and Investing Stocks and Investing
Tue, August 2, 2022
[ 12:00 AM ] - WOPRAI
Amit Daryanani Maintained (ANET) at Buy with Increased Target to $145 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Eric Stine Maintained (AMRC) at Strong Buy with Decreased Target to $82 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Stephen Gengaro Maintained (AMRC) at Strong Buy with Decreased Target to $82 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Brandon Nispel Maintained (AMT) at Buy with Increased Target to $300 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Joseph Moore Maintained (AMD) at Buy with Decreased Target to $101 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Andrew Mok Downgraded (AMED) to Strong Sell and Decreased Target to $95 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (BIRD) at Buy with Decreased Target to $140 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mike Dahl Downgraded (BLDR) to Hold and Increased Target to $79 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ryan Gilbert Downgraded (BLDR) to Hold on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Trey Grooms Maintained (BLDR) at Buy with Increased Target to $90 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matthew Bouley Maintained (BLDR) at Buy with Increased Target to $93 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
David Manthey Maintained (BLDR) at Buy with Increased Target to $100 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Keith Hughes Maintained (BLDR) at Strong Buy with Increased Target to $85 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Dane Leone Upgraded (BLUE) to Buy and Held Target at $8 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Brooke Roach Initiated (BURL) at Strong Buy and Held Target at $183 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Moshe Orenbuch Maintained (CACC) at Sell with Decreased Target to $440 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Brian Mullan Downgraded (CBRL) to Hold and Held Target at $100 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (AXNX) at Strong Buy with Increased Target to $77 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Adam Maeder Maintained (AXNX) at Buy with Increased Target to $82 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Larry Biegelsen Maintained (AXNX) at Buy with Increased Target to $87 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Cecilia Furlong Maintained (AXNX) at Buy with Increased Target to $80 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (AXNX) at Strong Buy with Increased Target to $85 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (BAH) at Buy with Increased Target to $105 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jeff Johnson Maintained (ZBH) at Buy with Decreased Target to $138 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (ZI) at Buy with Increased Target to $54 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Phil Winslow Maintained (ZI) at Buy with Decreased Target to $80 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kash Rangan Maintained (ZI) at Strong Buy with Decreased Target to $63 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Taylor McGinnis Maintained (ZI) at Strong Buy with Increased Target to $53 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Block Maintained (ARQT) at Strong Buy with Increased Target to $50 on, Aug 2nd, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (ARQT) at Buy with Increased Target to $45 on, Aug 2nd, 2022

Vikram Purohit Maintained (ARQT) at Buy with Increased Target to $45 on, Aug 2nd, 2022


Published on 2024-10-27 22:22:29 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $39 to $45 on, Aug 2nd, 2022.

Vikram has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram

  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Tuesday, June 7th, 2022
  • Uy Ear of "Mizuho" Maintained at Strong Buy with Decreased Target to $57 on, Thursday, April 7th, 2022
Contributing Sources